Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade - Wikidata - awgldk - TriplyDB

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade

http://www.wikidata.org/entity/Q34976218

about

Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges Concise review: pancreas regeneration: recent advances and perspectives Regulatory T-cell therapy in transplantation: moving to the clinic A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation What is the purpose of launching the World Journal of Transplantation?Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease.Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.International workshop: islet transplantation without borders enabling islet transplantation in Greece with international collaboration and innovative technology.Beneficial effect of insulin treatment on islet transplantation outcomes in Akita mice.Strategies toward single-donor islets of Langerhans transplantation.Islet Oxygen Consumption Rate (OCR) Dose Predicts Insulin Independence in Clinical Islet Autotransplantation Breakdown in peripheral tolerance in type 1 diabetes in mice and humans Regenerative medicine as applied to general surgery Update on islet transplantation.Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation Within a Biologic Resorbable Scaffold.State of the art of clinical islet transplantation and novel protocols of immunosuppression.Regulation of immune responses by mTOR.CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.Generating β cells from stem cells-the story so far Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.Clinical application of regulatory T cells in type 1 diabetes.Biologic agents in islet transplantation.Islet cell xenotransplantation: a serious look toward the clinic Pancreatic islet transplantation: from dogs to humans and back again.Avoiding immunological rejection in regenerative medicine.Memory T cells in organ transplantation: progress and challenges.The state of the art of islet transplantation and cell therapy in type 1 diabetes.Factors expressed by murine embryonic pancreatic mesenchyme enhance generation of insulin-producing cells from hESCs.Human islet viability and function is maintained during high-density shipment in silicone rubber membrane vessels.Islet oxygen consumption rate dose predicts insulin independence for first clinical islet allotransplants.Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro.Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation.Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.Pancreas-After-Islet Transplantation in Nonuremic Type 1 Diabetes: A Strategy for Restoring Durable Insulin Independence.Islet heparan sulfate but not heparan sulfate proteoglycan core protein is lost during islet isolation and undergoes recovery post-islet transplantation.

P2860

Q26769878-A6A4B729-8568-43AB-9B6B-B2FBEA851C5B Q27010290-2D196941-8557-4A77-8F81-A4B60C32720A Q27013646-8EA46944-3DC1-4DD9-97CF-AF6CE5FC777C Q27025869-62978794-7B48-49C6-9559-187220D39459 Q27320218-FF042B8C-8DEB-45A5-A59A-1A1C0334CD76 Q30430008-CA742F48-B80B-43F3-8EE8-A0D80BE49AF5 Q30430239-D2767A50-F704-48CF-A4B4-0F50B2A58544 Q30486465-A0D00EF0-1952-4007-B6F2-906F7E21CB75 Q33776912-69F77CA7-7630-40B9-B067-7FBB1107451F Q33848529-FAE61202-A8AF-4DFE-B19D-B4385FA712A0 Q33900815-59791169-5696-41A3-AA6B-8FB9C90E67CA Q35151554-75C89879-D5AD-41A5-9D7A-938455C77AA2 Q35707270-B0A0E44B-B746-4C28-B77C-002B79546C97 Q35741476-466EDE80-F146-4C74-A150-156E86417A1C Q35765731-CA96ED74-30E5-421A-B32E-8E9F738706B4 Q35892487-4F630EC2-4044-4CA1-9369-7B1C67FC6B1C Q36065843-8CCEF2F2-0D8D-418F-AD39-E68BEE02B1B1 Q37088225-F6F76DBA-F3D2-4956-B7E4-9947C091D3B1 Q37528715-55289E5A-2D31-44BC-951B-50BF49856BC0 Q37741918-D05D6F0D-7875-475A-A8CB-3A3A8A6C4D09 Q37914760-350D7C71-8386-4246-B0AF-58BFB50E78ED Q37963950-4CB83501-6B09-4CC7-8827-4DF38B62EB00 Q37968576-CDF748CA-AC6B-466E-9FF4-ACEDCAED7108 Q38016900-669FFA1B-BD5E-46C5-A4C2-454DA2F4192A Q38063547-3579886F-4F6C-429F-90A4-8D3E7778CBFE Q38102783-F7A5C028-9FCB-425B-B9DA-FF6AF2742558 Q38126884-4BF1DCB3-AEC2-40A8-A73C-C7EFFDCB53DB Q38210098-8B25B9A0-FABA-42AC-AA4D-5FD2069DD2DB Q38218567-BE1D38E7-210D-498C-8F81-510176AEF535 Q38453650-F29E794C-20DA-48F9-A8D3-989CD2CB089B Q38753494-4B059E59-D588-4E05-99A1-8AEB805CC5D9 Q38753743-64DEA3BD-515C-4B41-8572-77ED05AD8F53 Q40124013-66829A9F-903D-4E58-8F96-AEF83AB2272A Q42013461-55B3ED30-5F19-4DD9-B73F-26C63ECB8C9B Q42238633-A5D69E80-0F08-4840-BC2D-C833A9D039E0 Q42395113-12A178ED-35A0-4823-8638-5079422EDBA7 Q43655192-FC1720F9-F8B9-4E15-B2F2-FFA35F3B1C41 Q44842989-638CB120-C024-463F-B0A4-A6CE809DD882 Q46728801-5AB83867-660C-4980-A552-0C8FC98C0B6D Q53457111-F657296E-3579-4EBB-A826-D94ADEA55368

P2860

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade

http://www.wikidata.org/entity/Q34976218

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Islet transplantation in type ...... sion or costimulation blockade

@ast

Islet transplantation in type ...... sion or costimulation blockade

@en

Islet transplantation in type ...... sion or costimulation blockade

@nl

type

label

Islet transplantation in type ...... sion or costimulation blockade

@ast

Islet transplantation in type ...... sion or costimulation blockade

@en

Islet transplantation in type ...... sion or costimulation blockade

@nl

prefLabel

Islet transplantation in type ...... sion or costimulation blockade

@ast

Islet transplantation in type ...... sion or costimulation blockade

@en

Islet transplantation in type ...... sion or costimulation blockade

@nl

P1433

Q34976218-677400E9-D02F-4B4E-B038-B0AFF4A7DFD6

P1476

Q34976218-FCC16CB8-CC72-415A-80D5-0E6EE34638F0

P2093

Q34976218-1D160630-288C-4B98-A80E-4FA3A1D35150

Q34976218-27D5E783-FDA4-436D-8517-ED6B8F973B91

Q34976218-2B65141D-C971-4A5B-8E15-9E5E40AFF1A4

Q34976218-2E88030D-B2B4-484E-87B8-9CBC19CED5C4

Q34976218-33CCB8E7-23CF-4A6B-99F6-85094E2D1C85

Q34976218-34DCA717-9B24-4039-9324-EAD7FFF36577

Q34976218-3E3C0624-148A-4310-A315-2AE3B9D2FF0E

Q34976218-676B4876-D463-46F6-A311-5322ED9FF7DF

Q34976218-92B2A278-7E68-46D4-AF47-BAD4B815EB88

Q34976218-B7A6FDFD-0F4A-4560-940A-1EF29AF8C016

P2860

Q34976218-02CC0AB5-E70A-4D05-BD6B-7EAA6FDD3EFB

Q34976218-0A578FE7-25CC-4057-AA51-4DF1F1B62A73

Q34976218-10A643F5-8B1F-4367-A51C-60E5640AAD8F

Q34976218-15CEED2F-6806-4E15-9F96-85753D61388B

Q34976218-1AFEA04C-7AFF-4813-9DE1-D3E2129937DB

Q34976218-21186FDB-9D46-45E8-B178-0CA257EE9092

Q34976218-22D07CC8-038D-44DD-AAE5-82932A2D0E80

Q34976218-240BAE54-A1DA-4C38-9E70-4EB582596CC4

Q34976218-24C0F3A7-29F7-45D8-AEA1-BDDB9D3F2761

Q34976218-3B5548E7-0E3D-4485-93D5-31038DAED2FA

P304

Q34976218-1B8A59D2-1751-48D6-9444-4B1C8D869700

P31

Q34976218-AB522C21-1CF7-4F5B-9554-67561764859D

P356

Q34976218-E6C3AC50-4D33-4585-9373-2E8B6AEA9CD7

P433

Q34976218-53FC0C77-E128-43AA-A187-360BC927C99A

P478

Q34976218-58DF8ACD-E914-4775-BC9A-28394BA567C6

P577

Q34976218-2083D420-94E1-4691-B7FA-3EA56623E53A

P698

Q34976218-C469911A-D367-47C3-A39D-91CA189368AD

P932

Q34976218-CFFB8266-27F3-4463-8207-61E1D76BF5B0

P356

TP.0B013E3181FE1377

P1433

Transplantation

P1476

Islet transplantation in type ...... sion or costimulation blockade

@en

P2093

Andrew M Posselt

http://www.w3.org/2001/XMLSchema#string

Flavio Vincenti

http://www.w3.org/2001/XMLSchema#string

Gregory L Szot

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Bluestone

http://www.w3.org/2001/XMLSchema#string

Joan McElroy

http://www.w3.org/2001/XMLSchema#string

Lawrence Fong

http://www.w3.org/2001/XMLSchema#string

Lynda A Frassetto

http://www.w3.org/2001/XMLSchema#string

Marissa D Ramos

http://www.w3.org/2001/XMLSchema#string

Mehdi Tavakol

http://www.w3.org/2001/XMLSchema#string

Peter G Stock

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

The effect of prednisone on pancreatic islet autografts in dogs

Calcineurin inhibitor nephrotoxicity.

An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis.

Detection and measurement of urinary protein.

Posttransplant lymphoproliferative disorder.

Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period.

P304

1595-1601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E3181FE1377

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20978464

http://www.w3.org/2001/XMLSchema#string

P932

4296579

http://www.w3.org/2001/XMLSchema#string